Create a narrative

Fulgent Genetics Community

NasdaqGM:FLGT Community

1 Narratives written by author
0 Comments on narratives written by author
11 Fair Values set on narratives written by author

Create a narrative

Fulgent Genetics

AN

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

Expanding Hereditary Testing And Digital Tools Will Transform Genomic Medicine

Key Takeaways Expansion into new markets, partnerships, and specialty segments supports rising demand, revenue growth, and greater customer diversification. Investments in AI, digital pathology, and automation drive efficiency, margin expansion, and quality improvements, while legal shifts offer more stable market access.

US$22.67

FV

6.4% undervalued

9.49%

Revenue growth p.a.

0

0

8

Updated